Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 187

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 187
---
 purchase 5,991 Ordinary Shares owned by Medica III Investments Israel (B) LP; (vi) 49,636 Ordinary Shares and warrants to purchase 5,530 Ordinary Shares owned by Poalim Medica III Investments LP. The beneficial owners under Medica Group are: MCP Opportunity Secondary Program III L.P with 10.57% beneficial ownership, NYC Police Pension Fund with 8.8% beneficial ownership, Quantum Partners LDC with 13.2% beneficial ownership, and Migdal Insurance Company Ltd with 8.8% beneficial ownership. None of which include individuals who hold more than 5% interest. Medica III Management L.P., an entity held 50% by Dr. Ehud Geller and 50% by Batsheva Elran, is the managing entity of Medica III Fund. The principal business address of Medica III Investment is 60C Medinat Hayehudim, Herzliya, 4676670, Israel. |

| (7) | Consists of (1) 108,189 Ordinary Shares and warrants to purchase 11,683 Ordinary Shares held by SCP Vitalife Partners II L.P., and (2) 52,186 Ordinary Shares and warrants to purchase 3,902 Ordinary Shares held by SCP Vitalife Partners (Israel) II L.P. Mr. Jeff Dykan. is the general partner of the foregoing entities, and, as such, holds share voting and dispositive power over the shares held by the foregoing entities. The principal business address of SCP Vitalife Partners II L.P., is Messrs. Churchill and Weisman, 5 Great Valley Parkway, Suite 210, Malvern, Pennsylvania 19355. The principal business address of SCP Vitalife Partners (Israel) II L.P. is 15 Hatidhar, P.O. Box 2138, Raanana, Tel Aviv 4366517, Israel. |
| (8) | Consists of options to purchase up to 15,000 Ordinary Shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div align='center'>115

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div>

The following is a description
of the material terms of those transactions with related parties to which we, or our subsidiaries, are party.

Convertible Loans

In September of 2021, we
entered into several convertible loan agreements, or the 2021 CLAs, pursuant to which we obtained a convertible loan in the aggregate
amount of